"Weight loss brings impressive improvement in the control of diabetes," says Dr. Gary Foster, Director of the Center for Obesity Research and Education at Temple University School of Medicine, Chair of Nutrisystem's Scientific Advisory Board and head of the research team for Nutrisystem's first clinical trial. "A structured plan empowers overweight people with type 2 diabetes to transition from feeling overwhelmed by meal planning to instead making appropriate food choices that can have a positive impact on weight loss and blood glucose."
A third study, which used continuous glucose monitoring, compared glycemic control and variability during consumption of Nutrisystem D and participants' usual diets. While consuming Nutrisystem D, participants had lower average blood glucose and less variability. Glycemic variability – or fluctuations in blood sugar levels – is an independent risk factor that can contribute to complications of diabetes.
Anthony Fabricatore, Ph.D., Senior Director of Research and Development at Nutrisystem and the lead author of the study, said, "These findings are very encouraging, because the reduction in variability was noticeable even before significant weight loss. Also participants had fewer occurrences of high blood glucose without a significant increase in low blood glucose values."
Click here to view the study abstract. This study was presented at the 2012 Scientific Sessions of the American Diabetes Association.Nutrisystem D, in combination with counseling, has been clinically proven to be effective in people with type 2 diabetes, but it is also designed to be appropriate for overweight patients with type 1 diabetes or for those at risk for diabetes. Nutrisystem D Adds Access to Diabetes Educators As part of the enhanced plan, Nutrisystem D has now added Certified Diabetes Educators to its staff of nutritional counselors, providing easy access for Nutrisystem D customers and potential customers to diabetes experts who can address consumers' questions including those about use of the program to lose weight and help manage their blood glucose.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV